Control of fetal hemoglobin: new insights emerging from genomics and clinical implications
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Increased levels of fetal hemoglobin (HbF, alpha(2)gamma(2)) are of no consequence in healthy adults, but confer major clinical benefits in patients with sickle cell anemia (SCA) and beta thalassemia, diseases that represent major public health problems. Inter-individual HbF variation is largely genetically controlled, with one extreme caused by mutations involving the beta globin gene (HBB) complex, historically referred to as pancellular hereditary persistence of fetal hemoglobin (HPFH). These Mendelian forms of HPFH are rare and do not explain the common form of heterocellular HPFH which represents the upper tail of normal HbF variation, and is clearly inherited as a quantitative genetic trait. Genetic studies have identified three major quantitative trait loci (QTLs) (Xmn1-HBG2, HBS1L-MYB intergenic region on chromosome 6q23, and BCL11A on chromosome 2p16) that account for 20-50% of the common variation in HbF levels in patients with SCA and beta thalassemia, and in healthy adults. Two of the major QTLs include oncogenes, emphasizing the importance of cell proliferation and differentiation as an important contribution to the HbF phenotype. The review traces the story of HbF quantitative genetics that uncannily mirrors the changing focus in genetic methodology, from candidate genes through positional cloning, to genome-wide association, that have expedited the dissection of the genetic architecture underlying HbF variability. These genetic results have already provided remarkable insights into molecular mechanisms that underlie the hemoglobin 'switch'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
The American Journal of Human Genetics
S., J. (1950) · Population (French Edition) · doi:10.2307/1523704 · Cited by 5,028
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · cited 1×
“Identifying the common alleles will require large population samples for additional screening studies and even larger samples for replication, and possibly denser maps (62).”
BackgroundThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
Self-citationCommon and rare variants in multifactorial susceptibility to common diseases
Bodmer, W., & Bonilla, C. (2008) · Nature Genetics · doi:10.1038/ng.f.136 · Cited by 1,131
Common Genetic Variation and Human Traits
Goldstein, D. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0806284 · Cited by 920 · cited 1×
“Identification of rare alleles will also require next-generation DNA sequencing technologies and statistical analysis methods that enable genomewide sequence analysis in large samples (63).”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Cited by
Items 201–288 of 288
Proteomic Analysis of β-Thalassemia/HbE: A Perspective from Hematopoietic Stem Cells (HSCs)
Ponnikorn, S., Kong, S. P., Thitivirachawat, S., Tanjasiri, C., Tungpradabkul, S., & Hongeng, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85863 · Cited by 3
“The adult hemoglobin contains two components, the major hemoglobin, Hb A (α2β2), and the minor hemoglobin, Hb A2 (α2δ2) [1, 2].”
BackgroundThe Current State of Sickle Cell Disease Treatments [Part I]
Sarkar, A. A. (2022) · GEN Biotechnology · doi:10.1089/genbio.2022.29073.asa · Cited by 3
Belmokhtar, I., Belmokhtar, K. Y., Lhousni, S., Charif, M., Sidqi, Z., Seddik, R., Choukri, M. A., Bellaoui, M., & Boulouiz, R. (2024) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2024.110840 · Cited by 2
Meher, S., Thakur, A. K., Sahu, S. K., Patel, S., Panda, B. K., Das, K., Dehury, S., Sahoo, S., Pandey, M., & Dash, B. P. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201462 · Cited by 2
Helleberg, H., Bjørnsdottir, I., & Offenberg, H. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107353 · Cited by 2
Studying the some biochemical parameters for thalassemia patients in AL-Najaf province
Sarhan, N. H., Waheed, Z. A., Zayed, S. S., Rasool, M. B., & Rasool, M. B. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.6313 · Cited by 2
Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country
Coşkun, Ç., & Ünal, Ş. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2386067 · Cited by 2
“Small single nucleotide polymorphism (SNP) alleles in these QTL are often associated with elevated HbF and may have led to this difference [12,13].”
Oliveira, A. M. D. J., Fiuza, L. M., Figueiredo, C. V. B., da Guarda, C. C., Santiago, R. P., Yahouédéhou, S. C. M. A., Carvalho, S. P., Pacheco, A. P., Lyra, I. M., Adôrno, E. V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110458 · Cited by 2
Sickle Cell Disease in Africa and the Arabian Peninsula: Current Management and Challenges
Adekile, A. D., & Makani, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_14 · Cited by 2
Genome Editing of Erythroid Cell Culture Model Systems
Yik, J. J., Crossley, M., & Quinlan, K. G. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_15 · Cited by 2
NickAria, S., Haghpanah, S., Ramzi, M., & Karimi, M. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1463915 · Cited by 2
“However, this QTL does not show a Mendelian segregation and the role of the c XmnI site on Hb F production is unclear, but it may be linked with mediator factors, chromosome remodeling, chromosome interactions and linkage during transcription [8,18,19].”
BackgroundAslan, D., & Değermenci, Ş. (2022) · Thalassemia Reports · doi:10.3390/thalassrep12020007 · Cited by 2
Ropero, P., Peral, M., Sánchez-Martínez, L. J., Rochas, S., Gómez-Álvarez, M., Nieto, J. M., González, F. A., Villegas, A., & Benavente, C. (2023) · ANALES RANM · doi:10.32440/ar.2022.139.03.rev09 · Cited by 2
Modifier Genes in the Haemoglobinopathies
Marzo, R. D., Calzolari, R., Rund, D. G., & Maggio, A. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022443 · Cited by 2
Bhagat, S. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00483 · Cited by 1
Al-Shaikh, F. S., Deifalla, A., Sequeira, R. P., & Woodman, A. (2025) · Expert Review of Hematology · doi:10.1080/17474086.2025.2546575 · Cited by 1
“Furthermore, in contrast to others [38,39], no significant associations between Xmn1-HBG2 (rs7482144) and BCL11A (rs11886868) and HbF level were found.”
Younus, L. A., Al-Zubaidy, H. F. S., Abdulrudha, K. H., Nasser, F. A., & Kudhair, A. H. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00824-2 · Cited by 1
“Nominally, this SNP in BCL11A is linked to HbF levels, In relation to the HBS1L-MYB intergenic region (HMIP), which is found at haplotype block 2, was the most significant linked SNP in sickle cell anemia and beta-thalassemia among Chinese, European, and African individuals [20].”
An intergenic silencer region regulates HBG expression
Zhu, X., Liu, L., Li, Y., Takezaki, M., Bombin, S., Yu, A., Pendergast, M. A., Sheehan, V., Kuppers, D. A., Bleris, L. G., et al. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100046 · Cited by 1
Cohen, D. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00005-7 · Cited by 1
Risk-Based Therapies for Sickle Cell Disease
Meier, E. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_4 · Cited by 1
Flansburg, C. N., Balentine, C. M., Grieger, R. W., Lund, J., Ciambella, M., White, D., Coris, E. E., Gonzalez, E. C., Stone, A. C., & Madrigal, L. (2019) · Southern Medical Journal · doi:10.14423/smj.0000000000000976 · Cited by 1
HbE and HbF levels in HbE/βO-thalassemia are heterogeneous
Tatu, T., Sakdasirisathaporn, P., Wongchompoo, P., & Nawarawong, W. (2011) · Journal of Associated Medical Sciences · Cited by 1
Dehghani, H., Ghobakhloo, S., & Neishabury, M. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1189931 · Cited by 1
“However, functional studies have not been able to demonstrate how this role is performed (20,21).”
BackgroundTangpan, L., & Tatu, T. (2015) · Journal of Associated Medical Sciences · Cited by 1
Precision Medicine for Sickle Cell Disease: Discovery of Genetic Targets for Drug Development
Pace, B. S., Lopez, N. H., Zhu, X., & Li, Y. (2016) · InTech eBooks · doi:10.5772/64817 · Cited by 1
“Early genomewide family genetic studies [82] and subsequent GWAS identified the XmnI-HBG2, HBS1MYB, and BCL11A loci that account for ~40% of inherited HbF variance [83].”
BackgroundAlbarawi, D. J., Balatay, A. A., & Al-Allawi, N. A. S. (2018) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_22_18 · Cited by 1
“‐158 C>T rs7481244 (Xmn I polymorphism), which has been reported to be associated with 3–11 folds increase in Gγ‐globin chain production, by increasing the rate of the transcription of the gene, in conditions characterized by hematopoietic stress.[5,19,20] In this series of Iraqi Kurds who are β‐thal carriers, nearly…”
ResultTatu, T. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1954_17 · Cited by 1
Under Reported Potentials of Low Foetal Haemoglobin Concentration in Sickle Cell Disease
Dogonzo, Y. I., Charles, E. O., & Nnanna, E. T. (2022) · International Journal of Blood Research and Disorders · doi:10.23937/2469-5696/1410080 · Cited by 1
Ababio, G. K., Ekem, I. A. E., Acquaye, J. K., Oppong, S. Y., Amoah, A. G. B., Brandful, J., & Quaye, I. K. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10438-1 · Cited by 1
“As more elements and their genetic relationships and evolution (Thein et al. 2009; Adeyemo et al. 2018) in β-globin gene are discovered, so will the understanding of the disease phenotype grow.”
Mechanistic and Biological Perspectives on Erythropoiesis
Bresnick, E. H., Papayannopoulou, T., & Migliaccio, A. R. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104286 · Cited by 1
Ameer jkhcey ibrahim, N. S. M., Mohammed, N. S., & Sulaiman, S. A. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s08.170 · Cited by 1
dos Santos, N. D. J. G. (2012) · Americanae (AECID Library) · Cited by 1
Machine Learning-Based Identification of Sickle Cell Disease Subphenotypes in Clinical Trial DataPreprint
Xiao, W., Oneal, P. A., Wang, M., Mehta, N. H., Liu, Q., Zhang, R., Perrine, S. P., & Ryan, Q. C. (2025) · medRxiv · doi:10.1101/2025.06.01.25328537 · Cited by 1
Transcription Factors, Chromatin Loops & Blood Cells
Stadhouders, R. (2014) · RePub (Erasmus University Rotterdam) · Cited by 1
Current challenges in GWAS integration and fine-mapping for variant interpretationPreprint
Ahmed, O. Y., Saravanan, N., Rovsing, A. B., Simpson, D., Devarajan, A., Gunn, S., Singh, T., Lappalainen, T., & Sanjana, N. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.04.736511 · Cited by 1
“For example, the first approved gene editing therapy (for sickle-cell anemia and beta thalassemia) targets a GWAS locus near BCL11A associated with persistent fetal hemoglobin (HbF) in adults 4 .”
Evolutionary pathway of pseudogenization of globin genes, α5 and β5, in genus Oryzias
Maruyama, K., Wang, B., Ishikawa, Y., Yasumasu, S., & Iuchi, I. (2015) · Development Genes and Evolution · doi:10.1007/s00427-015-0509-0
Developmental timing in aquatic embryos: linking intraspecific heterochrony and evolution
Tills, O. (2013) · PEARL (University of Plymouth) · doi:10.24382/1805
Jorna, R. (2013) · RePub (Erasmus University Rotterdam)
Sickle Cell Disease as a Multi‐Factorial Condition
Steinberg, M. H., & Verhovsek, M. M. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0006021.pub3
Developmental Maturation within the Hematopoietic System
Arora, N. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Moleirinho, A. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/3tnj-a883
Role of Sox6 and Coup-TFII transcription factors in the regulation of hemoglobin switching
Elangovan, S. (2014) · BOA (University of Milano-Bicocca)
Gene Therapy for Haemoglobinopathies
Goodman, M., & Malik, P. (2016) · Wiley eBooks · doi:10.1002/9780470015902.a0025347
Ferreira, J. P. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
van den Heuvel, A. (2015) · RePub (Erasmus University Rotterdam)
Pule, G. D. (2016) · Open University of Cape Town (University of Cape Town)
Estudo de polimorfismos associados ao aumento da expressão de Hemoglobina Fetal (HbF)
Pereira, C. I. A. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
THE ROLE OF KLF1 IN REGULATING γ-GLOBIN GENE REPRESSORS
Kovilakath, A. (2017) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/mhnx-3e92
ABSENCE OF SP1 TRANSCRIPTION FACTOR VARIANT IN 102 IRAQI PATIENTS WITH BETA THALASSEMIA INTERMEDIA
Albarawi, D. J., Alalsaidissa, J. N. J., & Al-Allawi, N. A. S. (2018) · Duhok Medical Journal · doi:10.31386/dmj.2017.11.1
Nicolau, M. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tangpan, L., Jansai, T., Kerdpoo, S., Kiewkarnkha, T., Limveeraprajak, E., & Tatu, T. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1671862
“5% cutoff level([17]), accounting for a 51% prevalence of high FC trait in this cohort.”
BackgroundPotential New Gamma-Globin Regulators: In vivo analysis of their role in the hematopoietic system
Hoeboer, S. (2019) · RePub (Erasmus University Rotterdam)
Targeted Fetal Hemoglobin Induction Therapy May Need a Blood-Brain Barrier
Quinn, C. T. (2015) · The Hematologist · doi:10.1182/hem.v12.5.4311
Obeidi, N., Tamaddon, G., Ranjbaran, R., Khamisipour, G., & Saberi, F. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100934
Janbaz, A., & Rezaei, A. (2020) · Egyptian Academic Journal of Biological Sciences. B, Zoology · doi:10.21608/eajbsz.2020.133373
Pattabhi, S., Lotti, S. N., Berger, M. P., Singh, S., & Rawlings, D. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.30.450644
Gbadero, D. G., Olutogun, T., Aworinde, O., Oluwadare, L. P., Abolarin, A. T., Farayola, L., & Adeyeye, M. C. (2021) · Research Journal of Health Sciences · doi:10.4314/rejhs.v9i3.6
Noninvasive estimation of the arterial partial pressure of oxygen in NICU infants
McDonell, J., Bates, M. L., Carr, L. J., McNamara, P. J., & Jenkins, N. (2021) · doi:10.17077/etd.005882
Sickle Cell Disease as a Multifactorial Condition
Verhovsek, M. M., & Steinberg, M. H. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0006021.pub2
Tall, F. G., Ndour, E. H. M., Djité, M., Barry, O. K., Kandji, P. M., Guéye, P. M., Cissé, A., & Sall, P. L. (2022) · African Journal of Biochemistry Research · doi:10.5897/ajbr2022.1154
“Indeed, HMIP-2 is characterized by eleven SNPs, which all showed a strong association with HbF levels in European patients, but only some of these SNPs showed a significant association in patients of African origin (Thein et al., 2009).”
BackgroundIgbineweka, N. E., Pilarski, A., Rooks, H., Breton, A., Hall, H., Joshi, D., Meeks, D., Chevassut, T. J. T., Thein, S. L., & Menzel, S. (2022) · Annals of Hematology & Oncology · doi:10.26420/annhematoloncol.2022.1403
“[1] In some cases, higher HbF levels could have been present before the onset of disease, but the causes of this could have influenced risk for the development of manifest disease, or impacted disease progression.”
BackgroundSelf-citationNigam, N., Kumar#, R., Verma, N., & Tripathi, S. (2022) · Family Medicine and Primary Care Open Access · doi:10.29011/2688-7460.1000206
Tatu, T., Tondee, W., Khamtong, P., Tangphan, L., & Jaitiang, J. (2023) · Journal of Associated Medical Sciences · doi:10.12982/jams.2024.006
戴, 晓. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112388
Ahmadifard, A., Maroofi, N., Tehrani, M. M., Dabestani, T., Maleki, M. S. M., Bayrami, S., & Banan, M. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.7.33
“To date, three quantitative trait loci (QTLs) have been identified which associated with HbF levels [4].”
BackgroundRoy, S., Bhattacharya, P., Dutta, A. K., & Das, M. K. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2024.01284
Machine Learning-Based Identification of Sickle Cell Disease Subphenotypes in Clinical Trial DataPreprint
Ryan, Q. C., Xiao, W., Oneal, P. A., Wang, M., Mehta, N., Liu, Q., Zhang, R., & Perrine, S. P. (2025) · Research Square · doi:10.21203/rs.3.rs-6770839/v1
Hemoglobin C Disease With Splenomegaly and With Factor II Mutation Gene Thrombophilia: A Case Report
Vázquez-Folch, S. J., Jiménez-Berríos, G. A., Izquierdo, N., & Vazquez, V. J. (2025) · Cureus · doi:10.7759/cureus.91937
“While the disease course is generally mild compared to other hemoglobinopathies such as sickle cell disease (SCD), complications such as gallstones, splenic sequestration, and rare thrombotic events may occur [5].”
Genetic variations in the β-globin cluster: influence on levels of fetal hemoglobin
Santos, R. A. J. M. D. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/79vk-9a83
Nkya, S., Mwita, L. A., Mgaya, J., Kumburu, H. H., van Zwetselaar, M., Menzel, S., Mazandu, G. K., Sangeda, R., Chimusa, E. R., & Makani, J. (2020) · Figshare · doi:10.6084/m9.figshare.12440711
Self-citationCtBP represses adult β-like globin expression in haematopoiesis
Yik, J. (2017) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/19981
Estudo de variantes genéticas associadas ao aumento de Hemoglobina Fetal na população Portuguesa
Pinto, V. A. M. V. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
SANTOS, B. M. D. A. F. D. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ierardi, R. (2010) · BOA (University of Milano-Bicocca)
Dampier, C., & Sil, S. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198818762.003.0026_update_001
Mécanismes moléculaires de l’érythropoièse normale
Cico, A. (2017) · theses.fr (ABES) · doi:10.70675/2f88a634z6ea0z4b7fzbd98z34c66128e3c7
Abdelrahman, A., Talaat, R. M., El-Halfawy, I. A., Alalwi, M. R., & Rizk, D. M. Y. (2026) · BMC Genomic Data · doi:10.1186/s12863-026-01436-4
“Decreased MYB levels are linked to slower cell proliferation and faster erythroid differentiation, which raises the possibility that changes in intrinsic MYB levels can influence HbF through the cell cycle [33].”
Sickle Cell Disease: Historical Overview and Current Therapies
Babatunde, O. O., Bibby, M. G., Atala, A., Almeida-Porada, G. D., & Porada, C. D. (2026) · Prenatal Diagnosis · doi:10.1002/pd.70195
Genetic milieu determines clinical phenotype
Al-Khatti, A. A. (2026) · Blood Global Hematology · doi:10.1016/j.bglo.2026.100104
Tetrahydrouridine pre-treatment increases tissue exposure of 14 C-decitabine in mice
Helleberg, H., Bjørnsdottir, I., Petersen, S. B., & Offenberg, H. (2026) · Xenobiotica · doi:10.1080/00498254.2026.2689078
“Foetal haemoglobin (HbF) is the dominant form of Hb during the early stage of development (thein et al. 2009; adekile 2021). during this period, between 10 weeks of gestational age and up to 6 months after birth, individuals genetically predisposed to develop SCd are largely unaffected (Sankaran…”
Talhar, S., Patil, B., Ambulkar, P. S., Waghmare, J. E., Jain, J., Jain, M., Gangane, N., & Das, D. (2026) · PubMed Central · doi:10.71480/nmj.v67i5.1469
“[18] The Arab-Indian β -globin haplotype, which predominates in the Indian population, is associated with elevated HbF levels.”
Pinto, V. A. M. V. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Supporting information 1 of Time Domains of Hypoxia Responses and -Omics Insights
Yu, J. J., Non, A. L., Heinrich, E. C., Gu, W., Alcock, J., Moya, E. A., Lawrence, E. S., Tift, M. S., O'Brien, K. A., Storz, J. F., et al. (2022) · doi:10.3389/fphys.2022.885295.s001
Structural and Functional Characterization of the MBD2-NuRD Co-Repressor Complex
Desai, M. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/fesx-3e41
Metadata
- Authors
- Thein, S. L., Menzel, S., Lathrop, M., & Garner, C.
- Affiliations
- King's College London (GB)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- University of California, Irvine (US)
- Corresponding author
- Thein, S. L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-06
- Volume
- 18
- Issue
- R2
- Pages
- R216-R223
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2758709
- OpenAlex
- W2121678970
- Semantic Scholar
- 24f312a7a63abd9a348d7cd92da05ea68713d111
- Cited by
- 250
- References
- 64
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 15 · 2019: 15 · 2018: 10 · 2017: 24 · 2016: 16 · 2015: 19 · 2014: 19 · 2013: 15 · 2012: 16
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL069259, R01-HL69259-03)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- fetal hemoglobin, sickle cell disease, beta-thalassemia, hereditary persistence of fetal hemoglobin, quantitative trait loci, HBG2, HBS1L-MYB, BCL11A, beta-globin gene, HBB mutations, genome-wide association study, positional cloning, candidate genes, cell proliferation and differentiation
- MeSH terms
- Animals, Erythrocytes, Fetal Hemoglobin, Humans, Genetic Variation, Quantitative Trait, Heritable, Genomics, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.